EUVIMEDEUVIMED entdecken
Crossref

Biochemical insight into gut microbial imbalance in Covid-19 and post vaccination heart attacks

Mohamed Gamil Mehanna, Turky Omar Asar, Habib Changal Mudasir, Sherif Edris, Hadiah Bassam Al Mahdi, Ahmed F Bakry, Mustafa Zeyadi, Mirza Rafi Baig, Salma Naqvi, Fahad A Al-Abbasi, Omar A Al-Bar, Vikas Kumar und 1 weitere

World Journal of Microbiology and Biotechnology · 2025

DOI: 10.1007/s11274-025-04431-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Microbiology and Biotechnology, 2025. Verfasst von Mohamed Gamil Mehanna und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Science, King Abdulaziz University, 21589, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Dysbiosis, COVID-19, Myocardial Infarction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gut dysbiosis (GD) influences myocardial infarction (MI), by promoting inflammation. Investigating compositional shifts in proinflammatory versus beneficial bacterial taxa may reveal novel biomarkers and therapeutic interventions. This study analysed stool samples from 30 patients who experienced myocardial infarction following COVID-19 infection or vaccination, and 20 healthy controls, using 16S rRNA sequencing to investigate gut microbial imbalances. OTUs were identified, and microbial differences were examined via PCA and PLS-DA to explore biomarkers and interventions. MI patients exhibited reduced Prevotella (17.19% vs. 30% in controls) and elevated Escherichia (16.11% vs.0. 28%), Salmonella (2.58% vs. 0.08%), and Bacteroides (15.91% vs. 8.18%), indicating proinflammatory Microbiota. At phylum level, Firmicutes increased (45.80% vs. 40.87%), Proteobacteria rose (13.27% vs. 9.91%), and beneficial Actinobacteria declined (2.78% vs. 3.67%). PCA showed distinct clustering, confirmed by Partial Least Squares Discriminant Analysis, highlighting heightened inflammation-driving taxa. Although Faecalibacterium appeared variably, it was overall diminished in MI patients, likely fueling immune activation. However, Bifidobacterium (2.06% vs. 2.57%) and Lactobacillus (0.63% v. 0.99%) decreased, compromising intestinal barrier integrity. Females had higher Fusobacterium (1.85% vs. ~ 0%) and Streptococcus (2.28% vs. 0.16%), whereas males exhibited increased Desulfovibrio (1.60% vs. 0.08%) and Akkermansia (1.02% vs. 0.04%). Finally, Enterobacteriaceae surged from 0.41% to 10.04%, exacerbating inflammatory cascades and underscoring dysbiosis in MI pathophysiology. Findings highlights pivotal role of dysbiosis in MI, with elevated proinflammatory bacteria (Escherichia, Salmonella, Proteobacteria) and reduced beneficial SCFA-producing taxa (Bifidobacterium, Lactobacillus) worsening inflammation. Sex-specific microbial alterations, characterized by an enrichment of Fusobacterium and Streptococcus in females and elevated levels of Desulfovibrio and Akkermansia in males, underscore their potential utility as clinical biomarkers for risk stratification. Targeted microbiota therapies can enhance cardiac care outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDysbiosisCOVID-19Myocardial InfarctionCOVID-19 VaccinesHumansMaleFemaleMiddle AgedRNA, Ribosomal, 16SAgedFecesBacteriaSARS-CoV-2Vaccination

Stichwörter der Autor:innen

BiomarkersGut dysbiosisInflammationMicrobiotaMyocardial InfractionProinflammatory

Substanzen

RNA, Ribosomal, 16SCOVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Science, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
  • Department of Biology, College of Science and Arts at Alkamil, University of Jeddah, Jeddah, Saudi Arabia.
  • Department of Biology, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Department of Research and Development, Al Borg Diagnostics, Jeddah, Saudi Arabia.
  • Department of Molecular Biology, Al Borg Diagnostics, Jeddah, Saudi Arabia.
  • Department of Clinical Pharmacy & Pharmacotherapeutics. Dubai Pharmacy College for Girls, Dubai Medical University, Dubai, United Arab Emirates.

Zitieren

APA

Mehanna, M. G., Asar, T. O., Mudasir, H. C., Edris, S., Al Mahdi, H. B., Bakry, A. F., Zeyadi, M., Baig, M. R., Naqvi, S., Al-Abbasi, F. A., Al-Bar, O. A., Kumar, V., & Anwar, F. (2025). Biochemical insight into gut microbial imbalance in Covid-19 and post vaccination heart attacks. World Journal of Microbiology and Biotechnology. https://doi.org/10.1007/s11274-025-04431-6

Vancouver

Mehanna MG, Asar TO, Mudasir HC, Edris S, Al Mahdi HB, Bakry AF, et al. Biochemical insight into gut microbial imbalance in Covid-19 and post vaccination heart attacks. World Journal of Microbiology and Biotechnology. 2025. doi:10.1007/s11274-025-04431-6

BibTeX
@article{Mehanna2025,
  author = {Mehanna, Mohamed Gamil and Asar, Turky Omar and Mudasir, Habib Changal and Edris, Sherif and Al Mahdi, Hadiah Bassam and Bakry, Ahmed F and Zeyadi, Mustafa and Baig, Mirza Rafi and Naqvi, Salma and Al-Abbasi, Fahad A and Al-Bar, Omar A and Kumar, Vikas and Anwar, Firoz},
  title = {Biochemical insight into gut microbial imbalance in Covid-19 and post vaccination heart attacks},
  journal = {World Journal of Microbiology and Biotechnology},
  year = {2025},
  doi = {10.1007/s11274-025-04431-6}
}
Kostenlos starten →